Biotech pauses trial after second patient death linked to gene therapy
- Posted on June 16, 2025
- By Washington Post
- 2 Views
Biotech pauses trial after second patient death linked to gene therapy
Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.
